Truist Financial
SPRO icon

Truist Financial’s Spero Therapeutics SPRO Stock Holding History

Truist Financial’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,627
Closed -$143K – 2550
2020
Q2 		$143K Buy
+10,627
New +$119K ﹤0.01% 2251

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Truist Financial's SPRO Position: Q3 2020 in Review

Truist Financial sold out of Spero Therapeutics (SPRO) in Q3 2020, closing a stake of 10,627 shares — an estimated $143K sold.

Truist Financial first reported a position in SPRO in Q2 2020 and held it in 1 quarter. The position peaked at $143K in Q2 2020. 78 funds tracked by Wall St. Rank hold SPRO as of Q3 2020.

  • Truist Financial reported no remaining Spero Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Truist Financial sold 10,627 Spero Therapeutics shares in Q3 2020, an estimated $143K.
  • Truist Financial first reported a position in Spero Therapeutics in Q2 2020 and held it in 1 quarter.
  • Truist Financial's Spero Therapeutics position peaked at $143K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2020.

Based on Truist Financial's 13F filing for Q3 2020, filed 13 Nov 2020.